Literature DB >> 12521612

Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis.

Jean-François Dhainaut1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12521612     DOI： 10.1016/s0002-9610(02)01137-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  2 in total

1.  Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients.

Authors:  Mitchell Jay Cohen; Mariah Call; Mary Nelson; Carolyn S Calfee; Charles T Esmon; Karim Brohi; Jean Francois Pittet
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

Review 2.  Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis.

Authors:  James E Frampton; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.